In fact, Namali and colleagues demonstrated that tumors developed following the injection of colon cancer cells over-expressing tumstatin, endostatin, or TSP-1 finally escaped angiogenesis inhibition [61]. This evidence concerns the gene COL18A1 and colonic neoplasm.